The UK's leading charity for patient support & information - General enquiries call 01223-870008

Promise in US Trial for Advanced Metastatic RCC

New data from a Phase 1 clinical trial shows that ARMO BioSciences‘  immunotherapy AM0010 (pegilodecakin), alone or in combination with immune checkpoint inhibitors, shows high and durable clinical responses in patients with advanced renal cell carcinoma (RCC).

Kidney Cancer Awareness Week 5-9 February 2018

Kidney Cancer UK and Kidney Cancer Scotland are pleased to announce that Monday 5th to the Friday 9th February will be Kidney Cancer Awareness Week 2018 across the United Kingdom, #KCAW2018, culminating in 'Green Friday' on 9th February.

Vaccine for Renal Cancer Passes Early Test

A vaccine against metastatic renal cell carcinoma appears to have some activity in patients who receive engineered autologous dendritic cell infusions, researchers reported here at the International Kidney Cancer Symposium.